Valuation dashboard for BGM Group Ltd. (BGM) with P/E N/A, P/B 0.15, EV/EBITDA -9.61 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Operating from Chengdu, People's Republic of China, BGM Group Ltd. engages in the manufacturing and supply of active pharmaceutical ingredients (APIs), traditional Chinese medicine (TCM) derivatives, and various other related products across China.
Analysis Summary
BGM Group Ltd. reported revenue of $37.9M in the most recent fiscal year, growing at a 5-year CAGR of -5.4%.
Trailing-twelve-month margins: gross margin 12.8%, operating margin -23.4%, net margin -44.2%.
At the current price of $9.35, BGM has negative trailing earnings (P/E not meaningful) and an ROE of -5.37%. Market capitalisation stands at $119M.
Balance sheet quality for BGM: current ratio of 1.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.15 |
| EV / EBITDA | -9.61 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-0.19 |
| vs Current Price | -102.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| BGM | BGM Group Ltd. | $119M | 0.15 | -5.4% | |
| EWTX | Edgewise Therapeutics, Inc. | $4.3B | 9.95 | -32.1% | |
| CLOV | Clover Health Investments, Corp. | $2.3B | 6.10 | -5.4% | |
| TAK | Takeda Pharmaceutical Company Limited | $58.9B | 49.40 | 1.17 | 2.6% |
| TEVA | Teva Pharmaceutical Industries Limited | $46.2B | 62.40 | 5.91 | 9.2% |
| HLN | Haleon plc | $38.8B | 18.10 | 1.79 | 9.9% |
| 0M3Q.L | Zoetis Inc. | $34.2B | 11.75 | 9.47 | 69.3% |
| 0SAN.L | Sandoz Group AG | $30.3B | 56.50 | 4.06 | 7.0% |
Price
| Price | $9.35 |
| Market Cap | $119M |
| Exchange | NASDAQ |
| Country | CN |
Profitability
| Return on Equity | -5.37% |
| Return on Invested Capital | -2.80% |
| Return on Assets | -4.85% |
| Gross Margin | 12.81% |
| Operating Margin | -23.42% |
| Net Margin | -44.22% |
Related companies: ANIP · AVDL · CLOV · EWTX · GPCR · MESO · PAHC
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of BGM: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks